Sigma-Aldrich Stockholders Approve Merck Acquisition
News Dec 08, 2014
Sigma-Aldrich stockholders voted to adopt the previously announced merger agreement providing for the acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany at a special meeting of stockholders. Sigma-Aldrich stockholders also approved, on an advisory, non-binding basis, compensation that may become payable to named executive officers as a result of the acquisition.
As previously announced, on September 22, 2014, the board of directors for Sigma-Aldrich approved the merger agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for $140.00 per share in cash.
QIAGEN Receives FDA Clearance for JAK2 Diagnostic TestNews
Expanded use of ipsogen test provides diagnostic testing needs for all myeloproliferative neoplasms in line with the latest WHO guidelines.READ MORE
Moss that Removes Lead Contamination From WaterNews
Researchers have demonstrated that moss can be a green alternative for decontaminating polluted water and soil. The study shows that in particular, the moss Funaria hygrometrica tolerates and absorbs an impressive amount of lead (Pb) from water.READ MORE
Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UKNews
Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK. Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments.READ MORE